ZBIO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $46,863,839.00

Insider Selling (Last 12 Months): $0.00

ProShares UltraPro Short Nasdaq Biotechnology Insider Trading History Chart

ProShares UltraPro Short Nasdaq Biotechnology Share Price & Price History

^$12.45

▼ -2.05 (-14.14%)

As of 11/20/2024 01:00 AM ET

This Bull Market Indicator called NVDA at $116

From WealthPress | Ad

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

ProShares UltraPro Short Nasdaq Biotechnology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/18/2024	Leon O Moulder Jr	CEO	Buy	7,500	$15.00	$112,500.00	168,655
9/20/2024	Leon O Moulder Jr	CEO	Buy	5,000	$18.45	$92,250.00	1,672,039
9/18/2024	Leon O Moulder Jr	CEO	Buy	10,000	$17.91	$179,100.00	1,662,039
9/16/2024	Patrick G Enright	Director	Buy	440,000	$17.00	$7,480,000.00	774,530
9/16/2024	Sr One Capital Management, Llc	Major Shareholder	Buy	2,235,294	$17.00	$37,999,998.00	1,946,564
9/13/2024	Hongbo Lu	Director	Buy	58,823	$17.00	$999,991.00	58,823

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

SEC Filings (Institutional Ownership Changes) for ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO)

Zenas BioPharma Inc. is a clinical-stage global biopharmaceutical company. It involved in the development and commercialization of transformative immunology-based therapies for patients in need. The company's lead product candidate includes obexelimab and Fc?RIIb. Zenas BioPharma Inc. is based in WALTHAM, Mass.

Today's Range

Now: $12.45

$11.65

$14.61

50 Day Range

MA: $10.05

$10.02

$10.09

52 Week Range

Now: $12.45

$8.28

$18.64

Volume

418,910 shs

Average Volume

129,818 shs

Market Capitalization

$520.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ProShares UltraPro Short Nasdaq Biotechnology?: ProShares UltraPro Short Nasdaq Biotechnology's top insider investors include:
Sr One Capital Management, Llc (Major Shareholder)
Leon O Moulder Jr (CEO)
Patrick G Enright (Director)
Hongbo Lu (Director)
Learn More about top insider investors at ProShares UltraPro Short Nasdaq Biotechnology.